Statement Of Cash Flows [Abstract]

Mithra Pharmaceuticals S.A. - Filing #3183198

Concept 2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations before changes in working capital
80,538,000 EUR
68,572,000 EUR
Adjustments for decrease (increase) in trade and other receivables
341,000 EUR
2,186,000 EUR
Adjustments for increase (decrease) in trade and other payables
2,048,000 EUR
521,000 EUR
Adjustments for depreciation and amortisation expense and impairment loss (reversal of impairment loss) recognised in profit or loss
10,426,000 EUR
9,767,000 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from issue of bonds, notes and debentures
- EUR
122,401,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.